Literature DB >> 15672254

Two cases of orbital adenocarcinoma treated with heavy charged carbon particle irradiation.

Aki Hirai1, Atsushi Mizota, Seiichiro Mine, Jun-etsu Mizoe.   

Abstract

BACKGROUND: Orbital adenocarcinoma is a relatively rare, primary orbital malignant epithelial tumor, and shares the poor prognosis of orbital adenoid cystic carcinoma. We report the cases of two patients with orbital adenocarcinoma who were treated with heavy charged carbon particle irradiation and followed up for more 6 years.
METHOD: Two patients with orbital adenocarcinoma, 62 and 74 years old, received 57.6 GyE of heavy charged particle irradiation therapy.
RESULTS: In both cases, the size of the tumor gradually decreased after carbon ion irradiation therapy. No recurrences or metastasis of the tumor were found for more than 6 years.
CONCLUSION: Orbital adenocarcinoma has a poor prognosis in general. Two patients with orbital adenocarcinoma were treated with heavy charged carbon particle irradiation therapy and had a relatively good outcome and good prognosis. We believe that heavy charged carbon particle irradiation therapy is a promising therapy for orbital adenoid cystic carcinoma and adenocarcinoma.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15672254     DOI: 10.1007/s00417-004-1003-y

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  7 in total

1.  Where is the superiority of proton radiation for ocular tumours?

Authors:  Nikolaos E Bechrakis; Michael H Foerster
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2002-07       Impact factor: 3.117

2.  Intra-arterial chemotherapy: a welcome new idea for the management of adenocystic carcinoma of the lacrimal gland.

Authors:  R A Goldberg
Journal:  Arch Ophthalmol       Date:  1998-03

3.  Fractionated stereotactic radiation therapy for extracranial head and neck tumors.

Authors:  Y C Ahn; K C Lee; D Y Kim; S J Huh; I H Yeo; D H Lim; M K Kim; K H Shin; S Park; S H Chang
Journal:  Int J Radiat Oncol Biol Phys       Date:  2000-09-01       Impact factor: 7.038

4.  Neoadjuvant intracarotid chemotherapy for treatment of advanced adenocystic carcinoma of the lacrimal gland.

Authors:  M L Meldrum; D T Tse; P Benedetto
Journal:  Arch Ophthalmol       Date:  1998-03

5.  Carbon ion radiotherapy for stage I non-small cell lung cancer.

Authors:  Tadaaki Miyamoto; Naoyoshi Yamamoto; Hideki Nishimura; Masashi Koto; Hirohiko Tsujii; Jun-etsu Mizoe; Tadashi Kamada; Hirotoshi Kato; Shigeru Yamada; Shinroku Morita; Kyosan Yoshikawa; Susumu Kandatsu; Takehiko Fujisawa
Journal:  Radiother Oncol       Date:  2003-02       Impact factor: 6.280

Review 6.  Successful surgical treatment of liver and kidney metastases 25 years after a primary lacrimal gland tumor.

Authors:  C Blöchle; D M Lloyd; J R Izbicki; K Hamper; C E Brölschi
Journal:  Eur J Surg Oncol       Date:  1993-12       Impact factor: 4.424

7.  Current status of clinical particle radiotherapy at Lawrence Berkeley Laboratory.

Authors:  J R Castro; J M Quivey; J T Lyman; G T Chen; T L Phillips; C A Tobias; E L Alpen
Journal:  Cancer       Date:  1980-08-15       Impact factor: 6.860

  7 in total
  1 in total

Review 1.  Orbital Metastases: A Systematic Review of Clinical Characteristics, Management Strategies, and Treatment Outcomes.

Authors:  Paolo Palmisciano; Gianluca Ferini; Christian Ogasawara; Waseem Wahood; Othman Bin Alamer; Aditya D Gupta; Gianluca Scalia; Alexandra M G Larsen; Kenny Yu; Giuseppe E Umana; Aaron A Cohen-Gadol; Tarek Y El Ahmadieh; Ali S Haider
Journal:  Cancers (Basel)       Date:  2021-12-24       Impact factor: 6.639

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.